Biotech · Private company · Ames, IA, US
Neovaxsyn, Inc.
Track this companyFree. Adds Neovaxsyn, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- A novel strategy for the next generation rAAV gene therapy and vaccine vector productionFiscal year 2026 · $300KNIH RePORTER 1R43AI197694-01 · fetched Nov 12, 2026
- Nanovaccine for Eliciting bnAbs Against HIV-1Fiscal year 2024 · $2MNIH RePORTER 75N93024C00019-0-9999-1 · fetched Nov 12, 2026
- Development of a Next-Generation Immunoprevention Platform Against HIV-1Fiscal year 2024 · $300KNIH RePORTER 75N93024C00050-0-9999-1 · fetched Nov 12, 2026